首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 62 毫秒
1.
大规模区带离心纯化Vero细胞乙脑疫苗   总被引:1,自引:0,他引:1  
本文报道一种适合疫苗生产的大规模纯化Vero细胞乙脑疫苗的方法。原疫苗经适当浓缩和去除DNA处理后,用不连续蔗糖梯度(36%和60%)。32600g,速率区带离心4h。纯化后疫苗的效力比中国参考疫苗高出6倍以上,补体结合抗原比中国参考疫苗高4~8倍。总蛋白含量低于30μg/mL,牛血清含量降至0.5μg/mL以下,细胞残余DNA低于100pg/0.5mL。用此法连续制备三批纯化疫苗,其纯度和效力均高于日本鼠脑纯化疫苗。此法对于制备其它纯化Vero细胞疫苗也具有一定的参考意义。  相似文献   

2.
乙脑病毒SA14-14-2株疫苗原液经β丙内酯灭活Sepharose 4FF纯化后作为包被抗原,制备阳性替代品,应用间接ELISA法检测人血清中乙脑病毒抗体。建立内部质量控制血清标准,比较蚀斑减少中和试验(PRNT)与ELISA的相关性。检测46份乙脑相关血清的结果与国内同类试剂进行比较,阳性符合率为93.1%,阴性符合率为89.5%。在咸安地区3万多名2~14岁人群中进行乙脑病毒IgG抗体水平普查,阳性率22.5%,与国内同类试剂的符合率为95.7%,使用效果很好。  相似文献   

3.
地鼠肾细胞狂犬病疫苗原液经100 kD 膜浓缩 30 倍,分别选用(1)DEAE Sepharose CL-6B离子交换层析法;(2)Sephacry1 S-200 HR 分子筛选层析法;(3)二次蔗糖等密度区带离心法对其进行纯化。用此三种方法各试制3 批精制疫苗,结果表明,经DEAE Sepharose CL-6B离子交换层析纯化后疫苗总蛋白含量减少99% 以上,抗原比活性提高159 倍,抗原回收率达50% ,纯化疫苗以NIH 法效力测定平均为5.4 IU/2m l;经Sephacry1 S-200HR 分子筛层析纯化后疫苗总蛋白含量减少 98% 以上,抗原比活性提高41 倍,抗原回收率达63% ,纯化疫苗效力平均为6.25 IU/2m l;经一次蔗糖等密度区带离心法纯化后疫苗总蛋白含量减少98% 以上,抗原比活性提高321 倍,抗原回收率达43% ,纯化疫苗效力平均为6.18 IU/2m l,三种纯化疫苗均符合W HO 规程要求。  相似文献   

4.
通过对蔗糖梯度离心法纯化Vero细胞乙脑疫苗的纯化工艺进行分析,发现现行工艺中收取的病毒组分中,不同蔗糖浓度中病毒的纯度是不同的,而呈峰型且与病毒效力峰及蛋白浓度峰不重合。实验结果对今后工艺的改进具有指导意义。另外应用Sephacryl-s-1000凝胶层析法对乙脑病毒进行了纯化研究和分析,发现蔗糖梯度离心法和层析法纯化的病毒的纯度及回收率分别为291.46u/mg、96.01%和309.41 u/mg 65.08%,Sephacryl-s-1000凝胶层析法同样可以获得较高的纯度和收率。  相似文献   

5.
转瓶培养与生物反应器微载体培养乙脑病毒的比较   总被引:1,自引:0,他引:1  
分别用15L转瓶与15L生物反应器微载体(2.5g/L CytodexⅢ)系统培养Vero细胞并接种乙型脑炎病毒(简称乙脑病毒)。转瓶培养Vero细胞7~8d,细胞数最高能达到8×108;当单层细胞长至3.0~4.5×108时接种乙脑病毒,病毒滴度能达到6.5~6.98 lg PFU/ml,并能够连续收获4~5次;采用微载体系统培养Vero细胞,细胞密度最高能达到170×108;当单层细胞长至60~70×108时接种乙脑病毒,病毒滴度能达到7~7.5 lg PFU/ml,并能够连续收获13~15次。两种方式培养的乙脑病毒收获液分别经灭活、浓缩、柱层析纯化后制备Vero细胞乙脑纯化疫苗,各项检定指标均符合《中国药典》的相关要求。  相似文献   

6.
制备轮状病毒四价灭活疫苗,观察其在小鼠体内的抗体应答情况。实验采用轮状病毒原液经凝胶过滤层析纯化,灭活后配制四价疫苗,肌肉注射免疫小鼠,ELISA法测定小鼠血清IgA、IgG。将单价G1、G2、G3、G4型灭活病毒原液及四价轮状病毒灭活疫苗免疫小鼠后,均可刺激产生针对RV的高水平的特异性IgG抗体,但IgA应答较弱。表明四价轮状病毒灭活疫苗在小鼠中具备很好的免疫原性。  相似文献   

7.
为了研究不同年份生产的乙型脑炎减毒活疫苗病毒E蛋白基因稳定性,从分子水平控制乙型脑炎减毒活疫苗质量,确保疫苗安全性,本研究分析了不同年份生产的乙脑活疫苗病毒E蛋白基因核苷酸序列及编码的氨基酸序列,并与该疫苗原始种子、主种子、工作种子、乙脑病毒强、弱毒株进行比较。结果显示不同年份生产的乙脑活疫苗病毒E蛋白基因核苷酸序列与其原始种子、主种子、工作种子和基因库中登录的乙脑病毒弱毒株SA14-14-2的相应序列完全一致,与乙脑病毒强毒株SA14的E蛋白氨基酸序列比较有9个位点氨基酸发生了改变。不同年份生产的乙脑活疫苗病毒E蛋白基因稳定性表明该疫苗质量稳定、安全。  相似文献   

8.
地鼠肾细胞培养的CTN株狂犬病新疫苗研究   总被引:1,自引:0,他引:1  
应用细胞毒种代替豚鼠脑毒种制备狂犬病地鼠肾细胞纯化疫苗。将狂犬病毒CTN株在原代地鼠肾细胞(PHKC)传代适应,用病毒培养液上清作为生产用毒种,结果通过在PHKC传10多代,适应后病毒滴度达到了7.0LogLD50/ml,并应用适应株(CTN-LS-HK)细胞毒种制备三批疫苗,其效力在6.11-6.55IU/ml,高于用aG株豚鼠脑毒种制备的三批疫苗效力(3.77-5.85IU/ml)。  相似文献   

9.
目的建立基于NP蛋白检测的流感减毒活疫苗病毒滴度检测方法,并进行初步应用。方法对病毒接种方式、流感病毒感染MDCK细胞培养时间、一抗和酶标二抗的稀释度、封闭液等ELISA反应条件进行筛选优化。采用建立的方法检测3批流感减毒活疫苗原液和1批疫苗成品,并与鸡胚培养法检测结果进行比较。结果选择直接接种法作为接种方式,病毒感染细胞后培养48 h进行NP蛋白表达的检测; ELISA检测条件一抗稀释度为1∶4 000,酶标二抗稀释度为1∶4 000,2%牛血清白蛋白封闭2 h,检测结果 P/N值最大。用建立的方法检测流感减毒活疫苗原液及疫苗成品效力,与鸡胚培养法检测结果差异无统计学意义(P0.05),具有较好的一致性。结论建立了基于NP蛋白检测的流感减毒活疫苗效力试验方法,可用于生产过程中流感减毒活疫苗原液和成品的检定。  相似文献   

10.
肾综合征出血热纯化疫苗的SDS-PAGE分析   总被引:1,自引:0,他引:1  
为了证明蛑综合征出血热纯化疫苗的主要成分坦病毒蛋白,采用出血热纯化疫苗经浓缩后进行SDS-PAGE和Western-blotting分析。结果 经SDS-PAGE显示,肾综合征出血热纯化疫苗有三条蛋白带,分子量分别约为70kD、55kD和50kD,与汉坦病毒三种结构蛋白(糖蛋白G1、G2和核蛋白NP)的分子量相符;经Western-blotting显示,分子量50kD的蛋白带反应阳性,分子量70kD和55kD的蛋白带无反应,认定出血热纯化疫苗的主要成分为汉坦病毒蛋白,主要由G1、G2和NP三种结构蛋白构成。  相似文献   

11.
12.
13.
It has now been over twenty years since a novel herpesviral genome was identified in Kaposi's sarcoma biopsies. Since then, the cumulative research effort by molecular biologists, virologists, clinicians, and epidemiologists alike has led to the extensive characterization of this tumor virus, Kaposi's sarcoma-associated herpesvirus(KSHV; also known as human herpesvirus 8(HHV-8)), and its associated diseases. Here we review the current knowledge of KSHV biology and pathogenesis, with a particular emphasis on new and exciting advances in the field of epigenetics. We also discuss the development and practicality of various cell culture and animal model systems to study KSHV replication and pathogenesis.  相似文献   

14.
15.
16.
17.
Comprises species occurring mostly in subtidal habitats in tropical, subtropical and warm-temperate areas of the world. An analysis of the type species, V. spiralis (Sonder) Lamouroux ex J. Agardh, a species from Australia, establishes basic characters for distinguishing species in the genus. These characters are (1) branching patterns of thalli, (2) flat blades that may be spiralled on their axis, (3) width of the blade, (4) primary or secondary derivation of sterile and fertile branchlets and (5) position of sterile and fertile branchlets on the thalli. Application of the latter two characters provides an important basic method for separation of species into three major groups. Osmundaria , a genus known only in southern Australia, was studied in relation to Vidalia , and its separation from the Vidalia assemblage is not accepted. Species of Vidalia therefore are transferred to the older genus name, Osmundaria. Two new species, Osmundaria papenfussii and Osmundaria oliveae are described from Natal. Confusion in the usage of the epithet, Vidalia fimbriala Brown ex Turner has been clarified, and Vidalia gregaria Falkenberg, described as an epiphyte on Osmundaria pro/ifera Lamouroux, is revealed to be young branches of the host, Osmundaria prolifera.  相似文献   

18.
Fifteen chromosome counts of six Artemisia taxa and one species of each of the genera Brachanthemum, Hippolytia, Kaschgaria, Lepidolopsis and Turaniphytum are reported from Kazakhstan. Three of them are new reports, two are not consistent with previous counts and the remainder are confirmations of very scarce (one to four) earlier records. All the populations studied have the same basic chromosome number, x = 9, with ploidy levels ranging from 2x to 6x. Some correlations between ploidy level, morphological characters and distribution are noted.  相似文献   

19.
肝癌中HBV和HCV基因和抗原的分布及意义   总被引:1,自引:0,他引:1  
采用原位分子杂交方法检测HCV RNA及HBV X基因;采用免疫组织化学方法研究HCV核心抗原,非结构区C33c抗原及HBxAg在肝细胞肝癌中的定位及分布.结果表明(1)HCV RNA、HBV X基因在肝细胞肝癌组织检出率分别为40%(55/136)和82%(112/136).HCV RNA定位于癌细胞的胞浆内,阳性细胞呈散在、灶状及弥漫分布三种形式;HBV X基因在肝癌细胞中的分布呈胞浆型、核型及核浆型,阳性细胞也呈上述三种分布形式;(2)HCV C33c抗原、核心抗原在肝细胞肝癌中的阳性率为81%(133/164)及86%(141/164).C33c抗原定位于癌细胞及肝细胞的胞浆内;核心抗原既定位于癌细胞核中,又可定位于胞浆中.C33c抗原阳性细胞以灶状分布为主;而核心抗原阳性细  相似文献   

20.
For a plant selection model with frequency-independent viabilities, fertilities and selfing rates, it is shown that apart from global fixation, for certain parameter combinations a protected polymorphism and facultative fixation (either allele may become fixed according to initial frequencies) may both occur. Facultative fixation requires different selling rates for the dominant and recessive type. Protection of the polymorphism requires resource allocation for male and female function. In this connection the problem of purely genetically caused population extinction is discussed.
For general frequency dependence and regular segregation, the chances for establishment of a completely recessive gene are compared to those of a completely dominant gene. It is proven that the process of establishment of the recessive gene, despite a fitness advantage, may be considerably endangered by drift effects if random mating prevails. The recessive gene may reach the same effectivity in establishment as a dominant gene, only if the recessive homozygote mates exclusively with its own type during the period of establishment.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号